(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
Report in relation to renaming Herzog Park set to be withdrawn - 2Select Your Cherished Fish
- 3Building a Maintainable Closet: Individual Excursions in Moral Style
- 4Osteoporosis, the silent disease, can shorten your life − here’s how to prevent fractures and keep bones healthy
- 5Get away from the Tedious Drudgery: Go into Business Today!
- Inside Kathy Hilton’s Christmas pajama party: caviar bumps, champagne vending machines and a mansion full of Housewives
- Asia's Noteworthy Destinations: A Voyager's Aide
- Figure out How to Augment the Advantages of a Web-based Degree
- Dominating Monetary Administration: A Bit by bit Manual for Making an Individual Financial plan
- Islamic State group militants claim capture and execution of a Nigerian brigadier general
- Nutrient Rich Natural products: Lift Your Wellbeing
- How food assistance programs can feed families and nourish their dignity
- Europe's powerful Ariane 6 rocket launches Sentinel-1D Earth-observation satellite to orbit (video)
- Pocket-Accommodating Jeep Wrangler Buying Guide for Seniors
